Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of DeathDecember 22, 2010 12:34 pm | by U.S. Food & Drug Administration | News | Comments
FDA is currently reviewing information on this potential risk and will communicate any new recommendations once it has completed its review.
(University of Melbourne) Australian scientists have discovered that changes to a gene involved in brain development can lead to testis formation and male genitalia in an otherwise female embryo.
Advances in photodetector technology enable a fast enough exchange of cryptography key for ultra-secure video conferencing.
Honda Motor Co Ltd announced Dec 20, 2010, that it will start field tests of its electric vehicle (EV) and plug-in hybrid electric vehicle (PHEV) in Japan.
Organic PV and novel LCD technology are among the latest projects to receive financial backing as part of NIST's Technology Innovation Program.
Questions and answers about Abbott Diabetes Care to recall 359 different lots of glucose test strips
The U.S. Food and Drug Administration today announced the agency is working with Abbott Diabetes Care to recall 359 different lots of glucose test strips
Falsely low blood glucose results can lead patients to try to raise their blood glucose when it is unnecessary, or to fail to treat elevated blood glucose due to a falsely low reading.
CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company") today announced that it will be conducting a non-brokered private placement equity financing under which it will issue 6,000,000 units at a price of $0.05 per unit for gross proceeds of $300,000. Each unit will...
LOVELAND, Colo., Dec. 22, 2010 /- Heska Corporation (Nasdaq: HSKA ) announces the following Webcast:What: Heska Corporation Invites You to Listen to Its Special Meeting of Stockholders on the WebWhen: Wednesday, December 29, @ 9:00 a.m. (MST)Where: www.heska.com (click on the Special...
COLLEGE STATION, Texas, Dec. 22, 2010 /- Scott & White Healthcare has acquired approximately 98 acres of undeveloped land that will be the home for a new 143-bed acute care hospital project. The property was purchased from Weingarten Realty Investors and College Station ISD. The...
Bio-Chem Fluidics helps original equipment manufacturers (OEMs) address clogging waste lines in clinical diagnostic systems with its solenoid operated pinch valves.
GENEART AG: Squeeze Out of Minority Shareholders and Domination Agreement with Applied Biosystems Deutschland GmbH EffectiveDecember 22, 2010 6:45 am | by The Associated Press | News | Comments
Geneart AG / GENEART AG: Squeeze Out of Minority Shareholders and Domination Agreement with Applied Biosystems Deutschland GmbH Effective Processed and transmitted by Thomson Reuters. The issuer is solely responsible for the content of this announcement.Regensburg, December 22, 2010 - The...
(Inderscience Publishers) Running and swimming records are broken again and again at almost every international athletics event, But, can human performance continue to improve indefinitely? Will runners continue to accelerate off the starting blocks and reach the finish line in...
Teledyne Technologies Incorporated (NYSE: TDY) ("Teledyne") and DALSA Corporation (TSX: DSA) ("DALSA") jointly announced today that they have entered into a definitive agreement that provides for the acquisition of DALSA Corporation by a wholly-owned subsidiary of Teledyne.